- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:26 | BofA Maintains Buy on Eli Lilly (LLY), Expects 2027 Earnings to Fully Realize Value of Obesity Drug Launches | ||
| 15:26 | BMO Capital Boosts Google Cloud (GOOG) Outlook as Enterprise AI Adoption Hits Rapid Acceleration | ||
| 15:26 | BMO Capital Sees Impressive Guidance and Construction Cloud Momentum at Autodesk (ADSK) | ||
| 15:26 | Morgan Stanley Upgrades DexCom (DXCM), Cites Undervalued Recovery and G7 Margin Potential | ||
| 15:26 | BofA Trims Block (XYZ) PT After Consumer Finance Sector Review | ||
| 15:26 | Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026 | ||
| 14:26 | Jim Cramer Says Darden (DRI)'s Olive Garden is the OG | ||
| 14:26 | Micron (MU)'s a "Gating Factor," Says Jim Cramer | ||
| 14:26 | Jim Cramer Discusses CoreWeave (CRWV)'s AI Data Center Buildout | ||
| 14:26 | Jim Cramer Says "Oracle (ORCL) is the Linchpin" | ||
| 14:26 | "We're Gonna See Seagate (STX) Go Up," Says Jim Cramer | ||
| 14:26 | "We're Gonna See Western Digital (WDC) Go Up," Says Jim Cramer | ||
| 14:26 | "I Was Very Impressed" by Medline (MDLN)'s IPO, Says Jim Cramer | ||
| 14:26 | "We're Gonna See Sandisk (SNDK) Go Up," Says Jim Cramer | ||
| 14:26 | Rivian (RIVN) Needs to Raise Money, Says Jim Cramer | ||
| 13:26 | Why Analysts Favor Kiniksa Pharmaceuticals (KNSA) | ||
| 13:26 | Here is What Analysts Have to Say About Hinge Health (HNGE) | ||
| 13:26 | AI-Enabled Automation Driving Up Sentiment Towards Waystar (WAY) | ||
| 13:26 | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| 13:26 | BEACON Trial Data Makes Beam Therapeutics (BEAM) an Attractive Buy | ||
| 13:26 | Why Analysts are Rating Alkermes (ALKS) a Buy | ||
| 13:26 | Mizuho Securities Reaffirm Bullish Stance on Surgery Partners (SGRY) | ||
| 13:26 | Why Analysts See a Huge Upside for Dyne Therapeutics (DYN) | ||
| 13:26 | What Makes Vaxcyte (PCVX) So Attractive | ||
| 13:26 | Here is Why H.C. Wainwright Sees Immense Upside for Viking Therapeutics (VKTX) |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .